.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Greenline (CA) leaned into a two-pillar mix anchored by Flower at 35.54% share and Concentrates at 31.12% share, with Flower up 77.50% year over year and 0.09% month over month while Concentrates advanced 131.25% year over year and 14.22% month over month; Vapor Pens held 18.71% share with 48.59% year-over-year growth and 23.89% month-over-month growth, and Pre-Roll reached 14.51% share with 252.52% year-over-year growth and 22.38% month-over-month growth. The tail categories remain immaterial in share — Edible at 0.08% with a 41.11% month-over-month drop and Topical at 0.04% with 162.08% year-over-year growth and 24.20% month-over-month growth — while average price for the brand fell 5.94% year over year against an overall brand sales lift of 99.20% year over year; combined, this mix suggests the current surge is volume-led in inhalables rather than breadth-led across formats.
The mix shifts imply a positioning that trades rank for velocity in California Flower, where a category rank of 52 coexists with only 0.09% month-over-month growth in Flower but 23.89% in Vapor Pens and 22.38% in Pre-Roll, pointing to momentum skewing toward faster-turning, lower-priced inhalables. With Concentrates up 131.25% year over year and average price at $14.14 while Flower pricing sits higher at $25.58, the 5.94% brand-wide price decline aligns with a mix shift toward categories where share rose 18.71% and 14.51% respectively; this pattern implies Greenline (CA) is prioritizing wallet-entry formats to expand penetration, accepting mid-pack Flower rank at 52 as it tilts growth to adjacent inhalable segments.
Competitive Landscape
Greenline (CA) sits at rank #52 in CA Flower for June 2026, improving 37 positions year over year from #89, but slipping 2 spots from its peak at #50 in May 2026; this mix of a 37-place YoY climb and a 2-rank month-over-month dip indicates momentum that is not yet locked in. Against the leaders, STIIIZY advanced from #2 to #1 with 62.5% YoY sales growth while CAM moved from #3 to #2 with 56.2% YoY sales growth, and CannaBiotix (CBX) slid from #1 to #3 despite posting 2.4% YoY growth; relative to these shifts, Greenline (CA)’s rank improvement of 41.6% versus its prior #89 baseline contrasts with a short-term 4.0% pullback from its #50 high. The pattern implies Greenline (CA) has broken out of the lower tier but must convert recent rank volatility into sustained quarter-over-quarter gains to defend a top-50 foothold amid faster-climbing leaders.
Notable Products
Orange Zuava Badder (1g) delivered the standout move in June 2026 with a +64.95% month-over-month surge to rank 4, while Orange Tree (3.5g) vaulted to rank 2 on a +213.11% jump and Orange Tree Pre-Roll (1g) held rank 1 with a smaller +15.78% lift. With six of the top ten SKUs concentrated in Concentrates, the brand’s gains are anchored in extract formats even as a flagship Flower SKU added over $82,237 in one month. The pattern implies Greenline (CA) is leaning into high-velocity Concentrates while using the Orange Tree family across Flower and Pre-Rolls to stabilize rank leadership.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
